RSI spoločnosti Midatech Pharma Plc
Aká je hodnota metriky RSI spoločnosti Midatech Pharma Plc?
Hodnota metriky RSI spoločnosti Midatech Pharma Plc je 15.33
Aká je definícia metriky RSI?
Index relatívnej sily (Relative strength index - RSI 14) je technický ukazovateľ, ktorý sa radí medzi momentum indikátory a meria rýchlosť a zmenu ceny. Jeho hodnota sa pohybuje medzi 0 a 100 a používa sa na charakterizovanie prekupovaného a prepredaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Midatech Pharma Plc
Čomu sa venuje spoločnosť Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Firmy s metrikou rsi podobnou spoločnosti Midatech Pharma Plc
- Hodnota metriky RSI spoločnosti Sonasoft je 15.26
- Hodnota metriky RSI spoločnosti Therapeutics Acquisition Corp je 15.27
- Hodnota metriky RSI spoločnosti Vital Mobile je 15.28
- Hodnota metriky RSI spoločnosti China National Culture je 15.29
- Hodnota metriky RSI spoločnosti China Everbright je 15.30
- Hodnota metriky RSI spoločnosti OBJ je 15.30
- Hodnota metriky RSI spoločnosti Midatech Pharma Plc je 15.33
- Hodnota metriky RSI spoločnosti Bank of Gansu Co je 15.34
- Hodnota metriky RSI spoločnosti Advance Auto Parts je 15.37
- Hodnota metriky RSI spoločnosti Pason Systems je 15.37
- Hodnota metriky RSI spoločnosti The Conygar Investment PLC je 15.40
- Hodnota metriky RSI spoločnosti Future Data je 15.41
- Hodnota metriky RSI spoločnosti Score Media and Gaming je 15.44